Fig. 1From: Evidence-based medicine and clinical fluorodeoxyglucose PET/MRI in oncologyPET/MRI study comprising whole-body FDG-PET (a) and Short Tau Inversion Recovery (STIR) MRI (b) from a patient with recurrent myxoid liposarcoma. The skeletal metastases are more readily appreciated on the MRI than on FDG-PETBack to article page